Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

NCT06031688 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

56

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Lymphoscintigraphy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Ramucirumab
DRUG: Tepotinib

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]